8-K - Apimeds Pharmaceuticals US, Inc. (0001894525) (Filer)
Published . Updated .
Filed: 2026-10-13 AccNo: 0001213900-26-108780 Size: 238 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Directly affected
- APUS Apimeds Pharmaceuticals US
Named in this report.
Indirectly affected
- XPH STATE STREET SPDR S&P PHARMACEUTICALS ETF
GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Filed: 2026-10-13 AccNo: 0001213900-26-108780 Size: 238 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Apimeds Pharmaceuticals US (APUS)
| Company | When | Average | Largest gain | Largest drop | Prices |
|---|---|---|---|---|---|
| State Street Spdr S&P Pharmaceuticals Etf (XPH) | the next day | -0.91% | +0.60% | -3.94% | 3 |
| State Street Spdr S&P Pharmaceuticals Etf (XPH) | three days later | -2.47% | -2.45% | -2.52% | 3 |
Price since this story was published: Apimeds Pharmaceuticals US (APUS)
Since the first closing price after “8-K - Apimeds Pharmaceuticals US, Inc. (0001894525) (Filer),” Apimeds Pharmaceuticals US (APUS) is -19.02%. The S&P 500 fund (SPY) is -0.40% over the same days, a -18.62% difference versus the market.
| Company | When | Move | Status |
|---|---|---|---|
| Apimeds Pharmaceuticals US (APUS) | that day | -11.22% | final price |
| Apimeds Pharmaceuticals US (APUS) | the next day | -15.22% | final price |
| Apimeds Pharmaceuticals US (APUS) | two days later | -16.68% | final price |
| Apimeds Pharmaceuticals US (APUS) | three days later | -21.95% | final price |
| Apimeds Pharmaceuticals US (APUS) | three days earlier | +5.85% | final price |
| Apimeds Pharmaceuticals US (APUS) | five days earlier | +35.90% | final price |
| GLD | that day | -0.14% | final price |
| GLD | the next day | -1.62% | final price |
| GLD | two days later | +0.13% | final price |
| GLD | three days later | -0.03% | final price |
| GLD | three days earlier | -0.93% | final price |
| GLD | five days earlier | +0.03% | final price |
| QQQ | that day | -0.32% | final price |
| QQQ | the next day | -2.28% | final price |
| QQQ | two days later | -2.39% | final price |
| QQQ | three days later | -4.85% | final price |
| QQQ | three days earlier | +0.20% | final price |
| QQQ | five days earlier | +1.83% | final price |
| SPY | that day | 0.00% | final price |
| SPY | the next day | -1.08% | final price |
| SPY | two days later | -0.80% | final price |
| SPY | three days later | -1.89% | final price |
| SPY | three days earlier | -0.53% | final price |
| SPY | five days earlier | +0.14% | final price |
| TLT | that day | +0.42% | final price |
| TLT | the next day | +1.10% | final price |
| TLT | two days later | +2.52% | final price |
| TLT | three days later | +2.58% | final price |
| TLT | three days earlier | -0.21% | final price |
| TLT | five days earlier | -0.97% | final price |
Who gains and who loses around Apimeds Pharmaceuticals US (APUS)
Companies mentioned with this story
- APUS Apimeds Pharmaceuticals US
In “8-K - Apimeds Pharmaceuticals US, Inc. (0001894525) (Filer),” Apimeds Pharmaceuticals US (APUS) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> APUS
- XPH State Street Spdr S&P Pharmaceuticals Etf
For “8-K - Apimeds Pharmaceuticals US, Inc. (0001894525) (Filer),” State Street Spdr S&P Pharmaceuticals Etf (XPH) is linked, with no stored direction, medium confidence. Reason on file: GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
How “8-K - Apimeds Pharmaceuticals US, Inc. (0001894525) (Filer)” reaches Apimeds Pharmaceuticals US (APUS)
“8-K - Apimeds Pharmaceuticals US, Inc. (0001894525) (Filer)” (13 Oct 2026) reaches Apimeds Pharmaceuticals US (APUS) through this story.
What ties Apimeds Pharmaceuticals US (APUS) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> APUS
State Street Spdr S&P Pharmaceuticals Etf (XPH) is here too. Its reason reads: GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Dates and price levels for Apimeds Pharmaceuticals US (APUS)
APUS traded between 1.67 and 4.71 across 16 sessions. The latest close on file is 3.47. XPH traded between 61.54 and 68.95 across 20 sessions. The latest close on file is 62.24.
How solid “8-K - Apimeds Pharmaceuticals US, Inc. (0001894525) (Filer)” looks
48 out of 100
“8-K - Apimeds Pharmaceuticals US, Inc. (0001894525) (Filer)” scores 48 out of 100. The score uses 1 sources, a -14.14% difference versus the S&P 500 (SPY), and 2 linked companies.